メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の酪農用酵素市場の考察、機会分析、市場シェア、予測

Global Dairy enzymes Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 619931
出版日 ページ情報 英文 190 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=111.89円で換算しております。
Back to Top
世界の酪農用酵素市場の考察、機会分析、市場シェア、予測 Global Dairy enzymes Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023
出版日: 2018年03月19日 ページ情報: 英文 190 Pages
概要

当レポートでは、世界の酪農用酵素市場について調査分析し、市場概要、市場決定要因、市場区分、競合情勢、地域別の分析、企業プロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 市場概要

  • 進化と移行
  • 市場定義・範囲
  • 産業構造
  • 規制の枠組み
  • 総合市場分析
  • 推定分析
  • 戦略分析
  • 競合分析
  • 戦略的提言と主な結論

第3章 市場決定要因

  • 市場促進要因
  • 市場抑制要因
  • 市場の機会
  • 市場の課題

第4章 市場区分

  • 製品別
  • 用途別
  • エンドユーザー別

第5章 競合情勢

  • 主な戦略

第6章 地域別分析

  • 意思決定支援データベース・推定手法
  • 市場セグメント別の比較分析
  • 機会マトリクス
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他の地域

第7章 企業プロファイル

  • ABBOTT MEDICAL OPTICS, INC. (米国)
  • ALCON LABORATORIES, INC. (米国)
  • BAUSCH & LOMB INCORPORATED (米国)
  • CARL ZEISS MEDITEC AG (ドイツ)
  • ELLEX MEDICAL LASERS LIMITED (オーストラリア)
  • IRIDEX CORPORATION (米国)
  • LIGHTMED (米国)
  • LUMENISLTD. (イスラエル)
  • ニデック (日本)
  • OPTOTEK MEDICAL (スロベニア)
  • QUANTEL MEDICAL INC. (米国)
  • SCHWIND EYE-TECH-SOLUTIONS GMBH & CO. KG (ドイツ)
  • トプコン (日本)
  • VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (カナダ)
  • ZIEMER OPHTHALMIC SYSTEMS AG (スイス)
目次
Product Code: FFO-9510318

Enzymes refers to a class of proteins that not only helps in digestion process in living beings, but also play an important part in enhancing quality of food. It also enhances texture and flavour in the dairy products. The common enzymes used in the dairy product production include Rennet, Lactase, Catalase and Proteases etc. The global dairy enzymes market is expected to have a CAGR of about 7.18% during the forecast period 2016-2023. The major factors that are positively driving the dairy enzymes market includes the increasing consumption of dairy products, growing demand for low-lactose and lactose-free dairy products and environmental benefits associated with enzymes. However, restricted operational conditions and dairy allergies are negatively impacting towards the growth of dairy enzymes market.

Geographically, North America is expected to dominate the global dairy enzymes market by holding largest market share in terms of revenue over the forecast period 2016-2023. Owning to the advanced food processing industry in the region North America is expected to be the dominating region. Moreover, the presence of a large dairy industry also provides the dairy enzyme is also positively affecting the market across the North American region. Also, Asia Pacific is expected to be the fastest growing region for the dairy enzymes market during the forecast period due to growing food & beverage industry and dairy industries in the Asia pacific region.

Global dairy enzyme market report covers segmentation analysis of type and applications. Report further covers segments of ingredient segment that includes Lactase, Chymosin, Microbial Rennet, Lipase and Other. Microbial rennet accounted for the largest market share in terms of revenue in 2016 and is expected to dominate the market during the forecast period. Applications in Dairy enzymes are divided as Kefir, Yogurt, Cheese, Sour cream and others. Cheese accounted for the largest market share in terms of revenue in 2016 and it is expected to dominate the market during the forecast period.

The key players in the dairy enzyme market includes are DowDuPont (U.S.), Amano Enzymes (Japan), Novozymes (Denmark), Biocatalysts (U.K.), Cargill (U.S.), BENEO (Germany), and Kerry Group (Ireland) and SternEnzym (Germany). These players are following various strategies such as acquisition, merger, expansion and new product launch in order to strengthen the position across the world.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL OPHTHALMIC LASERSMARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING PREVALENCE OF OPHTHALMIC DISORDERS
    • 3.1.2. RAPID GROWTH IN GERIATRIC POPULATION
    • 3.1.3. INCREASING REGULATORY APPROVALS FOR OPHTHALMIC LASERS
    • 3.1.4. INCREASING INITIATIVES TO CONTROL VISUAL IMPAIRMENT
    • 3.1.5. RISING PREVALENCE OF CHRONIC DISEASES SUCH AS DIABETES
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. HIGH COST OF EQUIPMENT AND THERAPY
    • 3.2.2. AVAILABILITY OF ALTERNATIVE THERAPIES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. GROWTH POTENTIAL OFFERED BY EMERGING ECONOMIES
    • 3.3.2. TECHNOLOGICAL ADVANCEMENTS
  • 3.4. MARKET CHALLENGES
    • 3.4.1. LACK OF SKILLED PRACTITIONERS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL OPHTHALMIC LASERS MARKET BY PRODUCT
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL DIODE LASERS MARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL EXCIMER LASERS MARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL FEMTOSECOND LASERS MARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
      • 4.1.5.4. GLOBAL ND: YAG LASERS MARKET
        • 4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.4.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.4.4. KEY CONCLUSIONS
      • 4.1.5.5. GLOBAL SLT LASERS MARKET
        • 4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.5.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.5.4. KEY CONCLUSIONS
      • 4.1.5.6. GLOBAL OTHER LASERS MARKET
        • 4.1.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.6.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.6.4. KEY CONCLUSIONS
  • 4.2. GLOBAL OPHTHALMIC LASERS MARKET BY APPLICATION
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL AMD TREATMENT MARKET
        • 4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.1.4. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL CATARACT REMOVAL MARKET
        • 4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.2.4. KEY CONCLUSIONS
      • 4.2.5.3. GLOBAL DIABETIC RETINOPATHY TREATMENT MARKET
        • 4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.3.4. KEY CONCLUSIONS
      • 4.2.5.4. GLOBAL GLAUCOMA TREATMENT MARKET
        • 4.2.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.4.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.4.4. KEY CONCLUSIONS
      • 4.2.5.5. GLOBAL REFRACTIVE ERROR CORRECTIONS MARKET
        • 4.2.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.5.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.5.4. KEY CONCLUSIONS
      • 4.2.5.6. GLOBAL OTHER APPLICATIONS MARKET
        • 4.2.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.6.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.6.4. KEY CONCLUSIONS
  • 4.3. GLOBAL OPHTHALMIC LASERS MARKET BY END USER
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL AMBULATORY SURGICAL CENTERS MARKET
        • 4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.1.4. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL HOSPITALS MARKET
        • 4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.2.4. KEY CONCLUSIONS
      • 4.3.5.3. GLOBAL OPHTHALMIC CLINICS MARKET
        • 4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.3.4. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS AND ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHIC ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL OPHTHALMIC LASERS MARKET BY REGION 2014-2023
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ABBOTT MEDICAL OPTICS, INC. (U.S.)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. ALCON LABORATORIES, INC. (U.S.)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. BAUSCH & LOMB INCORPORATED (U.S.)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANALYSIS
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. CARL ZEISS MEDITEC AG (GERMANY)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. ELLEX MEDICAL LASERS LIMITED (AUSTRALIA)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. IRIDEX CORPORATION (U.S.)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. LIGHTMED (U.S.)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS
  • 7.8. LUMENISLTD. (ISRAEL)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. NIDEK CO., LTD. (JAPAN)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. OPTOTEK MEDICAL (SLOVENIA)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. QUANTEL MEDICAL INC. (U.S.)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. SCHWIND EYE-TECH-SOLUTIONS GMBH & CO. KG (GERMANY)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. TOPCON CORPORATION (JAPAN)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS
  • 7.14. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (CANADA)
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. STRATEGIC INITIATIVES
    • 7.14.4. SCOT ANALYSIS
    • 7.14.5. STRATEGIC ANALYSIS
  • 7.15. ZIEMER OPHTHALMIC SYSTEMS AG (SWITZERLAND)
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. STRATEGIC INITIATIVES
    • 7.15.4. SCOT ANALYSIS
    • 7.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL OPHTHALMIC LASERS MARKET BY PRODUCT 2014-2023 ($ MILLION)
  • 2. GLOBAL DIODE LASERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL EXCIMER LASERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL FEMTOSECOND LASERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL ND:YAG LASERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 6. GLOBAL SLT LASERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL OTHER LASERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL OPHTHALMIC LASERS MARKET BY APPLICATIONS 2014-2023 ($ MILLION)
  • 9. GLOBAL AMD TREATMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL CATARACT REMOVAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. GLOBAL DIABETIC RETINOPATHY TREATMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. GLOBAL GLAUCOMA TREATMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 13. GLOBAL REFRACTIVE ERROR CORRECTIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 14. GLOBAL OTHER APPLICATIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 15. GLOBAL OPHTHALMIC LASERS MARKET BY END USER2014-2023 ($ MILLION)
  • 16. GLOBAL AMBULATORY SURGICAL CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 17. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 18. GLOBAL OPHTHALMIC CLINICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 19. NORTH AMERICA OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 20. EUROPE OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 21. ASIA PACIFIC OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 22. REST OF THE WORLD OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBALDIODE LASERS MARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL EXCIMER LASERS MARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL FEMTOSECOND LASERS MARKET 2014-2023 ($ MILLION)
  • 4. GLOBAL ND:YAG LASERS MARKET 2014-2023 ($ MILLION)
  • 5. GLOBAL SLT LASERS MARKET 2014-2023 ($ MILLION)
  • 6. GLOBAL OTHER LASERSMARKET 2014-2023 ($ MILLION)
  • 7. GLOBAL AMD TREATMENT MARKET 2014-2023 ($ MILLION)
  • 8. GLOBAL CATARACT REMOVAL MARKET 2014-2023 ($ MILLION)
  • 9. GLOBAL DIABETIC RETINOPATHY TREATMENT MARKET 2014-2023 ($ MILLION)
  • 10. GLOBAL GLAUCOMA TREATMENT MARKET 2014-2023 ($ MILLION)
  • 11. GLOBAL REFRACTIVE ERROR CORRECTIONS MARKET 2014-2023 ($ MILLION)
  • 12. GLOBAL OTHER APPLICATIONS MARKET 2014-2023 ($ MILLION)
  • 13. GLOBAL AMBULATORY SURGICAL CENTERS MARKET 2014-2023 ($ MILLION)
  • 14. GLOBAL HOSPITALS MARKET 2014-2023 ($ MILLION)
  • 15. GLOBAL OPHTHALMIC CLINICS MARKET2014-2023 ($ MILLION)
  • 16. UNITED STATES (U.S.) OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 17. CANADA OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 18. UNITED KINGDOM (UK) OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 19. FRANCE OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 20. GERMANY OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 21. SPAIN OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 22. ROE OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 23. INDIA OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 24. CHINA OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 25. JAPAN OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 26. AUSTRALIA OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 27. ROAPAC OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 28. LATIN AMERICA OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
  • 29. MENA OPHTHALMIC LASERS MARKET 2014-2023 ($ MILLION)
Back to Top